dc.contributor.author | Demir, K | |
dc.contributor.author | Calangu, S | |
dc.contributor.author | Kaymakoglu, S | |
dc.contributor.author | Eraksoy, H | |
dc.contributor.author | Okten, A | |
dc.contributor.author | Besisik, F | |
dc.contributor.author | Boztas, G | |
dc.contributor.author | Cakaloglu, Y | |
dc.date.accessioned | 2021-03-05T20:25:56Z | |
dc.date.available | 2021-03-05T20:25:56Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Kaymakoglu S., Eraksoy H., Okten A., Demir K., Calangu S., Cakaloglu Y., Boztas G., Besisik F., "Spontaneous ascitic infection in different cirrhotic groups: Prevalence, risk factors and the efficacy of cefotaxime therapy", EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.9, ss.71-76, 1997 | |
dc.identifier.issn | 0954-691X | |
dc.identifier.other | av_d42e6f98-544a-489b-8961-ccde770c8587 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/140042 | |
dc.identifier.uri | https://doi.org/10.1097/00042737-199701000-00017 | |
dc.description.abstract | Objective: To investigate the prevalence of spontaneous ascitic infection (SAI) in different cirrhotic groups, the risk factors for development of SAI, and the efficacy of cefotaxime therapy. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | Spontaneous ascitic infection in different cirrhotic groups: Prevalence, risk factors and the efficacy of cefotaxime therapy | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 9 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 71 | |
dc.identifier.endpage | 76 | |
dc.contributor.firstauthorID | 118235 | |